The Cold Open
Vilon is two amino acids long. That's it. Lysine and glutamate, a dipeptide so small it barely qualifies as a peptide at all. It's sold as a longevity compound based on Russian mouse studies where it extended lifespan and reduced tumor incidence. This month: what Vilon actually does in animals, what it might be doing in humans, and why "extended mouse lifespan" is the most oversold claim in the peptide world.
Peptide of the Month: Vilon
What it is. Vilon, also called KE, is a synthetic dipeptide from Khavinson's Russian bioregulator program. Same lab as Pinealon from June. It's sold as an oral capsule in Russia and as injectable powder on the US grey market.
What it's supposedly for. Immune system support, lifespan extension, cancer prevention, general "geroprotection" in older adults. Also marketed for recovery after viral or bacterial illness.
The evidence as of today. The animal data is interesting. A 2000 mouse study found long-term Vilon extended lifespan, reduced tumor incidence, and increased physical activity in aging mice. A 2001 rat study found it inhibited bladder-cancer development. A 2023 in-vitro paper showed Vilon regulates SIRT1, a gene famously linked to longevity in yeast and mice. The one human study is a 520-patient Russian trial in adults convalescing from acute illness, reporting normalized immune parameters in 86 percent of cases.
One thing to know: "geroprotection" is a lab concept. The word describes a compound that extends lifespan or healthspan in animal models. It is not a clinical category. No regulator recognizes geroprotection as a drug indication, because no compound has proven it in humans.
Extending lifespan in a mouse is a scientific achievement. Extending lifespan in a human is a completely different problem that has never been solved by any drug, anywhere.
The catch. Not FDA-approved. The human evidence is a single large Russian trial published outside mainstream Western databases and summarized through Khavinson's review papers. The mouse lifespan data, while peer-reviewed and indexed, has not been replicated by independent Western labs in the 25 years since. The dipeptide's proposed mechanism, direct interaction with DNA to regulate gene expression, is unusual for a molecule that small and has not been reproduced outside the original research tradition.
Myth Check: "Vilon extends lifespan"
The forum version of this claim drops the word "mouse." What remains is "Vilon extends lifespan," which implies human lifespan, which is what users are actually paying for.
Here is the honest version. Vilon extended lifespan in mice, in one lab, in conditions not independently replicated. Mouse lifespan studies have a long history of not translating. Resveratrol extended mouse lifespan. So did rapamycin. So did metformin in some studies. None of those has proven lifespan extension in humans. The translation rate from "helps mice live longer" to "helps humans live longer" is, so far, zero.
That doesn't mean Vilon is useless. It means the claim on the label is the claim a regulator would require five large, independent human trials to let you print.
The rule: Every longevity compound ever tested has worked in mice before it failed in humans. "Worked in mice" is the starting line, not the finish line.
Not medical advice. Most peptides discussed in this newsletter are investigational or research chemicals. Talk to a clinician before starting anything.